Decreased Efficacy of Doxorubicin Corresponds With Modifications in Lipid Metabolism Markers and Fatty Acid Profiles in Breast Tumors From Obese vs. Lean Mice
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00306
Full Text
Open PDFAbstract
Available in full text
Date
March 17, 2020
Authors
Publisher
Frontiers Media SA